CULLER-JONES SYNDROME
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
A novel truncating variant of GLI2 associated with Culler-Jones syndrome impairs Hedgehog signalling.
|
30629636 |
2019 |
CULLER-JONES SYNDROME
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
GLI1 inactivation is associated with developmental phenotypes overlapping with Ellis-van Creveld syndrome.
|
28973407 |
2017 |
CULLER-JONES SYNDROME
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Role of GLI2 in hypopituitarism phenotype.
|
25878059 |
2015 |
CULLER-JONES SYNDROME
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
Pathogenic mutations in GLI2 cause a specific phenotype that is distinct from holoprosencephaly.
|
24744436 |
2014 |
CULLER-JONES SYNDROME
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Functional characterization of a heterozygous GLI2 missense mutation in patients with multiple pituitary hormone deficiency.
|
23408573 |
2013 |
CULLER-JONES SYNDROME
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ectopic posterior pituitary lobe without holoprosencephaly.
|
20685856 |
2010 |
CULLER-JONES SYNDROME
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ectopic posterior pituitary lobe without holoprosencephaly.
|
20685856 |
2010 |
CULLER-JONES SYNDROME
|
0.710 |
GeneticVariation
|
disease |
CLINVAR |
Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ectopic posterior pituitary lobe without holoprosencephaly.
|
20685856 |
2010 |
CULLER-JONES SYNDROME
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2.
|
15994174 |
2005 |
CULLER-JONES SYNDROME
|
0.710 |
GeneticVariation
|
disease |
CLINVAR |
Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features.
|
14581620 |
2003 |
CULLER-JONES SYNDROME
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features.
|
14581620 |
2003 |
CULLER-JONES SYNDROME
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
CULLER-JONES SYNDROME
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
CULLER-JONES SYNDROME
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
Holoprosencephaly
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous GLI2 loss of function mutations in humans have been reported in holoprosencephaly (HPE), HPE-like phenotypes associated with pituitary anomalies and combined pituitary hormone deficiency with or without other extra-pituitary findings.
|
30548673 |
2019 |
Holoprosencephaly
|
0.700 |
Biomarker
|
disease |
CTD_human |
Although normally indistinguishable from wild-type littermates, we demonstrate that mice with single-allele Gli2 mutations exhibit increased penetrance and severity of HPE in response to low-dose teratogen exposure.
|
27585885 |
2016 |
Holoprosencephaly
|
0.700 |
Biomarker
|
disease |
BEFREE |
Sonic Hedgehog (SHH) and GLI2, an obligatory mediator of SHH signal transduction, are holoprosencephaly (HPE)-associated genes essential in pituitary formation.
|
25056824 |
2015 |
Holoprosencephaly
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
However, the family presented here is unique as none of the three identified individuals with a GLI2 deletion showed any typical signs of holoprosencephaly, whereas all patients reported so far were referred for genetic testing because at least one member exhibited holoprosencephaly and related features.
|
25820550 |
2015 |
PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Role of GLI2 in hypopituitarism phenotype.
|
25878059 |
2015 |
Holoprosencephaly
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Pituitary insufficiency other than isolated diabetes insipidus is a rare finding of HPE, and occurs most frequently in patients with GLI2 mutations (the phenotype of which typically does not include frank neuroanatomic anomalies such as HPE); ours is the only described patient with a ZIC2 mutation and both anterior and posterior pituitary dysfunction.
|
24706429 |
2014 |
Holoprosencephaly
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Pathogenic mutations in GLI2 cause a specific phenotype that is distinct from holoprosencephaly.
|
24744436 |
2014 |
Holoprosencephaly
|
0.700 |
Biomarker
|
disease |
BEFREE |
Genomic GLI2 aberrations that mainly result in truncated proteins have been reported to cause holoprosencephaly or holoprosencephaly-like features, sometimes associated with hypopituitarism.
|
23408573 |
2013 |
Holoprosencephaly
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous nonsense GLI2 mutations have been reported in patients with isolated or combined pituitary hormone deficiency (CPHD), with or without holoprosencephaly.
|
22967285 |
2013 |
Holoprosencephaly
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in GLI2 have been found in association with holoprosencephaly (HPE) and HPE-like phenotype, with and without pituitary hormone deficiencies; as well as in patients with pituitary dysfunction with and without HPE craniofacial features.
|
23304807 |
2012 |
Holoprosencephaly
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the human GLI2 gene were first reported in association with defective anterior pituitary formation, panhypopituitarism, and forebrain anomalies represented by typical holoprosencephaly (HPE) and holoprosencephaly-like (HPE-L) phenotypes and postaxial polydactyly.
|
21204792 |
2012 |